Sort   by:  
 Page size 
UnknownProspective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer.
Not available
S-EPMC5015424 | biostudies-literature
UnknownGenetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.
Not available
S-EPMC4879695 | biostudies-literature
UnknownCorrection to: Bayesian methods: a potential path forward for sepsis trials.
Not available
S-EPMC10765909 | biostudies-literature
UnknownBayesian methods: a potential path forward for sepsis trials.
Not available
S-EPMC10634134 | biostudies-literature
UnknownA network analysis to identify mediators of germline-driven differences in breast cancer prognosis.
Not available
S-EPMC6965101 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownPrespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).
Not available
S-EPMC4898313 | biostudies-literature
UnknownPlasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088 | biostudies-literature
UnknownAVERT2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff.
Not available
S-EPMC4676118 | biostudies-literature
UnknownExploring threats to generalisability in a large international rehabilitation trial (AVERT).
Not available
S-EPMC4550737 | biostudies-literature
Sort   by:  
 Page size